Utility of clinical comprehensive genomic characterisation for diagnostic categorisation in patients presenting with hypocellular bone marrow failure syndromes.

In conclusion, genomic characterisation can improve diagnostic categorisation of patients presenting with hypoplastic BMF syndromes and should be routinely performed in this group of patients. PMID: 32054657 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32054657?dopt=Abstract

Source: Haematologica - February 12, 2020 Category: Hematology Authors: Blombery P, Fox L, Ryland GL, Thompson ER, Lickiss J, McBean M, Yerneni S, Hughes D, Greenway A, Mechinaud F, Wood EM, Lieschke GJ, Szer J, Barbaro P, Roy J, Wight J, Lynch E, Martyn M, Gaff C, Ritchie D Tags: Haematologica Source Type: research